HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Uterine Cancer

Uterine cancer, also known as endometrial cancer, originates in the lining of the uterus, called the endometrium. This form of cancer is most common among postmenopausal women, although it can affect women of any age. The exact cause of uterine cancer is not fully understood, but certain risk factors, such as hormonal imbalances, obesity, and a family history of the disease, may contribute to its development. Symptoms of uterine cancer often include abnormal vaginal bleeding, pelvic pain, and changes in urinary or bowel habits. Early detection is crucial for successful treatment, so women experiencing these symptoms should seek prompt medical attention. Diagnosis typically involves a combination of physical examinations, imaging tests, and biopsies. Treatment options for uterine cancer depend on factors such as the stage of the cancer, the patient's overall health, and individual preferences. Common approaches include surgery, radiation therapy, and chemotherapy. In some cases, a combination of these methods may be recommended. As with many cancers, adopting a healthy lifestyle can reduce the risk of uterine cancer. This includes maintaining a balanced diet, engaging in regular physical activity, and avoiding tobacco products. Routine check-ups and screenings can also aid in the early detection of any abnormalities. In conclusion, uterine cancer is a serious condition that primarily affects the endometrium of the uterus. Recognizing the symptoms and seeking medical attention promptly are crucial for effective treatment. A combination of medical interventions, lifestyle changes, and ongoing monitoring can contribute to a better prognosis for individuals diagnosed with uterine cancer.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp